Morphic Medical, Inc.
GIDYL
OTC PK
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 931.00K | 1.16M | 2.68M | 733.00K | 3.85M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.97M | 2.08M | 3.29M | 3.70M | 1.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 689.00K | 979.00K | 186.00K | 30.00K | 30.00K |
| Total Current Assets | 3.59M | 4.22M | 6.15M | 4.46M | 5.26M |
|
|
|||||
| Total Current Assets | 3.59M | 4.22M | 6.15M | 4.46M | 5.26M |
| Net Property, Plant & Equipment | 215.00K | 258.00K | 301.00K | 343.00K | 386.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.80M | 4.48M | 6.45M | 4.80M | 5.65M |
|
|
|||||
| Total Accounts Payable | 249.00K | 430.00K | 258.00K | 901.00K | 521.00K |
| Total Accrued Expenses | 666.00K | 583.00K | 831.00K | 1.23M | 886.00K |
| Short-term Debt | 222.00K | 263.00K | 318.00K | 5.98M | 5.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 172.00K | 172.00K | 171.00K | 171.00K | 170.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.31M | 1.45M | 1.58M | 8.28M | 6.58M |
|
|
|||||
| Total Current Liabilities | 1.31M | 1.45M | 1.58M | 8.28M | 6.58M |
| Long-Term Debt | 3.73M | 3.50M | 3.20M | 2.09M | 1.95M |
| Short-term Debt | 222.00K | 263.00K | 318.00K | 5.98M | 5.00M |
| Capital Leases | 27.00K | 67.00K | 106.00K | 145.00K | 182.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.06M | 5.01M | 4.89M | 10.51M | 8.71M |
|
|
|||||
| Common Stock & APIC | 295.96M | 294.49M | 290.04M | 284.46M | 284.27M |
| Retained Earnings | -298.00M | -295.63M | -293.80M | -290.17M | -287.33M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.03M | -1.14M | -3.76M | -5.71M | -3.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 776.00K | 601.00K | 5.33M | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 776.00K | 601.00K | 5.33M | -- | -- |
|
|
|||||
| Total Common Equity | -2.03M | -1.14M | -3.76M | -5.71M | -3.06M |
| Total Preferred Equity | 776.00K | 601.00K | 5.33M | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.26M | -535.00K | 1.57M | -5.71M | -3.06M |
|
|
|||||
